Loading…
Tan Alize Kozmetik Ve Temizlik Urunleri, a Turkish manufacturer of over-the-counter drug products including sunscreens, failed to conduct required identity testing on incoming components at high risk of contamination with diethylene glycol (DEG) or ethylene glycol (EG), specifically for glycerin and other ingredients used in their drug formulations. The company's manufacturing methods, facilities, and controls did not conform to Current Good Manufacturing Practice (CGMP) regulations under 21 CFR parts 210 and 211, resulting in adulterated drug products. The FDA identified significant violations of 21 CFR 211.84(d)(1), which requires testing to verify the identity of each component in a drug product.